Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PRKCG | P05129 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MYLK | Q15746 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2306795 | 0.80 | ACHE (0.32) | MEN1ALDH1A1PRKCGMAPTPRKCA | |
| SCHEMBL27822070 | 0.79 | PTGS2 (0.42) | ALDH1A1LMNATP53 | |
| SCHEMBL3624689 | 0.78 | PRKCE (0.37) | MEN1ALDH1A1PRKCGMAPTPRKCA | |
| SCHEMBL2304750 | 0.75 | GABRA1 (0.39) | LMNA | |
| SCHEMBL1613539 | 0.73 | ERN1 (0.33) | MAPTTDP1 | |
| SCHEMBL15873143 | 0.73 | IDO1 (0.33) | — | |
| SCHEMBL2305114 | 0.72 | — | — | |
| SCHEMBL12285411 | 0.70 | CYP11B1 (0.38) | MEN1ALDH1A1PRKCGMAPTPRKCA | |
| SCHEMBL9999680 | 0.70 | CA2 (0.37) | MEN1ALDH1A1PRKCGMAPTPRKCA | |
| SCHEMBL8475709 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023190912-A1 | POLAR-GROUP-CONTAINING OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME | 日本ポリケム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3978537-B1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | UNIV TOKYO (JP) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023033030-A1 | POLAR-GROUP-CONTAINING OLEFIN COPOLYMER AND METHOD FOR PRODUCING SAME | 国立大学法人 東京大学 | 2023-03-09 | — | — | WO | disclosed |
| EP-3208285-B2 | PRODUCTION METHOD OF AN ETHYLENE AND/OR ALPHA-OLEFIN-BASED IONOMER | JAPAN POLYETHYLENE CORP (JP) | 2023-01-25 | — | — | EP | disclosed |
| US-20220220239-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | THE UNIVERSITY OF TOKYO (JP) | 2022-07-14 | — | — | US | disclosed |
| CN-113874402-A | Polar group-containing olefin copolymer | 国立大学法人东京大学 | 2021-12-31 | — | — | CN | disclosed |
| WO-2020241715-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | 国立大学法人東京大学 | 2020-12-03 | — | — | WO | disclosed |
| US-10717855-B2 | Production method of ethylene-based ionomer and ethylene-based ionomer | JAPAN POLYETHYLENE CORPORATION (JP) | 2020-07-21 | — | — | US | disclosed |
| EP-3208285-B1 | PRODUCTION METHOD OF AN ETHYLENE AND/OR ALPHA-OLEFIN-BASED IONOMER | JAPAN POLYETHYLENE CORP (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-10550211-B2 | Process for producing ethylene/unsaturated carboxylic acid copolymer, and said copolymer | JAPAN POLYETHYLENE CORPORATION (JP) | 2020-02-04 | — | — | US | disclosed |
| US-20170306134-A1 | PRODUCTION METHOD OF ETHYLENE-BASED IONOMER AND ETHYLENE-BASED IONOMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| EP-3208285-A1 | PRODUCTION METHOD OF ETHYLENE-BASED IONOMER AND ETHYLENE-BASED IONOMER | Japan Polyethylene Corporation (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-20170210830-A1 | OLEFIN POLYMERIZATION CATALYST AND METHOD FOR PRODUCING OLEFIN POLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| EP-3173430-A1 | OLEFIN POLYMERIZATION CATALYST AND METHOD FOR PRODUCING OLEFIN POLYMER | Japan Polyethylene Corporation (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-20170002120-A1 | PROCESS FOR PRODUCING ETHYLENE/UNSATURATED CARBOXYLIC ACID COPOLYMER, AND SAID COPOLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| EP-3101040-A1 | METHOD FOR PRODUCING ETHYLENE/UNSATURATED CARBOXYLIC ACID COPOLYMER, AND SAID COPOLYMER | Japan Polyethylene Corporation (JP) | 2016-12-07 | — | — | EP | disclosed |
| US-20160237184-A1 | IMINE COMPOUND, NOVEL CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER | JAPAN POLYPROPYLENE CORPORATION (JP) | 2016-08-18 | — | — | US | disclosed |
| EP-3050892-A1 | IMINE COMPOUND AND NOVEL CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | Japan Polypropylene Corporation (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2351761-B1 | NOVEL METAL COMPLEX, AND METHOD FOR PRODUCING -OLEFIN POLYMER AND METHOD FOR PRODUCING -OLEFIN/(METH)ACRYLATE COPOLYMER EACH USING THE METAL COMPLEX | JAPAN POLYPROPYLENE CORP (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-2351761-A1 | NOVEL METAL COMPLEX, AND METHOD FOR PRODUCING -OLEFIN POLYMER AND METHOD FOR PRODUCING -OLEFIN/(METH)ACRYLATE COPOLYMER EACH USING THE METAL COMPLEX | Japan Polypropylene Corporation (JP) | 2011-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237184-A1 | IMINE COMPOUND, NOVEL CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER | ODC1, MACF1, MOGAT2 | MEN1 1491/4885ALDH1A1 1043/4885PRKCG 4355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.